Page last updated: 2024-08-05 11:44:31

thiocarbonyl compound

Any compound containing the thiocarbonyl group, C=S.

ChEBI ID: 50492

Members (17)

MemberDefinitionRole
2-amino-9-pentyl-3H-purine-6-thione2-amino-9-pentyl-3H-purine-6-thione
3-(5-cycloheptylidene-4-oxo-2-sulfanylidene-3-thiazolidinyl)propanoic acid3-(5-cycloheptylidene-4-oxo-2-sulfanylidene-3-thiazolidinyl)propanoic acid
5-cyclopentylidene-2-sulfanylidene-4-thiazolidinone5-cyclopentylidene-2-sulfanylidene-4-thiazolidinone
5-oxo-3-sulfanylidene-2H-1,2,4-triazine-6-carboxylic acid ethyl ester5-oxo-3-sulfanylidene-2H-1,2,4-triazine-6-carboxylic acid ethyl ester
6-mercapto-9-(tetrahydro-2-furyl)purine9-(2-oxolanyl)-3H-purine-6-thione
9-cyclopentyl-3H-purine-6-thione9-cyclopentyl-3H-purine-6-thione
cdecSulfallate
dixanthogenDixanthogen
elesclomolA carbohydrazide obtained by formal condensation of the carboxy groups of malonic acid with the hydrino groups of two molar equivalents of N-methylbenzenecarbothiohydrazideelesclomol
mdv 3100A benzamide obtained by formal condensation of the carboxy group of 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluorobenzoic acid with methylamine. Used for the treatment of of metastatic castration-resistant prostate cancer.enzalutamide
mercaptopurine3,7-dihydropurine-6-thione; mercaptopurine; purine-6-thiol
o-isopropyl xanthateProxan
prothioconazoleA member of the class of triazoles that is 1,2,4-triazole-3-thione substituted at position 2 by a 2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl group.2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione
thiocarbohydrazideThiocarbohydrazide
thiophosgenethiophosgene
thiouracilA nucleobase analogue that is uracil in which the oxo group at C-2 is replaced by a thioxo group.thiouracil
trithiocarbonic acidcarbonotrithioic acid

Research

Studies (10,227)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19905,411 (52.91)18.7374
1990's704 (6.88)18.2507
2000's961 (9.40)29.6817
2010's2,140 (20.93)24.3611
2020's1,011 (9.89)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials637 (5.86%)5.53%
Reviews906 (8.33%)6.00%
Case Studies660 (6.07%)4.05%
Observational61 (0.56%)0.25%
Other8,608 (79.18%)84.16%